News

Mr McKee is the executive vice president and CFO of Barr Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries. Prior to joining Barr, Mr McKee served as director of

The company has signed a lease for a 40,405 square foot building in Austin, Texas, that was previously used by Sorin Carbomedics. On-X Life will begin a 19-month

The approval of Lexapro for the treatment of adolescent depression was supported by two placebo-controlled studies, one conducted in adolescent patients taking Lexapro and one conducted in children

Navigenics, a genomics testing company, has acquired the Affymetrix clinical services laboratory, a CLIA-certified testing facility that provides molecular genome scanning using the Affymetrix GeneChip microarray platform. With

Roche has reported positive results from ToGA, an international Phase III trial investigating the benefit of Herceptin as the first therapy for patients with advanced and inoperable stomach

Gardner graduated from Concordia University and is a Certified General Accountant. “As we head into an accelerated period of growth with the launch of EclecticaTM and the growing

Xtent, a medical device company, has received CE Mark approval for its Custom NX drug-eluting stent system. The CE Mark indicates that the Custom NX drug-eluting stent (DES)

Champions Biotechnology has reported a net loss of $623,234, or $0.02 per basic share, for the third quarter of fiscal 2009, compared to a net income of $311,006,

Primary endpoints were met in all of the clinical programs required for the submission of the new drug application (NDA), comprising a long-term safety study and four efficacy